Researcher.Life Logo

Drug Target Insights : Impact Factor & More

eISSN: 1177-3928pISSN: 1177-3928
JournalOpen Access

Aims and Scope of Drug Target Insights

Drug Target Insights (DTI) is an international, indexed, peer-reviewed, open access, online only journal, published once a year. It covers current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central. Less

Key Metrics

CiteScore
4.3
SJR
Q2Clinical Biochemistry
SNIP
0.65
Recommended pre-submission checks
Powered by Paperpal by Editage

Drug Target Insights Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ABOUTSCIENCE SRL
Language English
Frequency Continuous publication
Article Processing ChargesEUR 1500
Publication Time8
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Drug Target Insights ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Drug Target Insights

Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
  • 23 Apr 2026
  • Drug target insights
Alternative model organisms: growing popularity, and the challenges.
  • 17 Feb 2026
  • Drug target insights
Antioxidant potential of a new macrocyclic bisbibenzyl and other compounds from Combretum molle: in vitro and docking analyses
  • 18 Dec 2025
  • Drug Target Insights
Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
  • 9 Dec 2025
  • Drug Target Insights
Co-occurrence of genes encoding carbapenem resistance and aminoglycoside resistance in clinical isolates of Enterobacterales
  • 27 Oct 2025
  • Drug Target Insights
Integrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
  • 21 Aug 2025
  • Drug Target Insights
Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma.
  • 23 Apr 2026
  • Drug target insights
Alternative model organisms: growing popularity, and the challenges.
  • 17 Feb 2026
  • Drug target insights
Antioxidant potential of a new macrocyclic bisbibenzyl and other compounds from Combretum molle: in vitro and docking analyses
  • 18 Dec 2025
  • Drug Target Insights
Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series
  • 9 Dec 2025
  • Drug Target Insights
Co-occurrence of genes encoding carbapenem resistance and aminoglycoside resistance in clinical isolates of Enterobacterales
  • 27 Oct 2025
  • Drug Target Insights
Integrated in vitro, microarray, and network pharmacology analysis reveals the multi-target anti-diabetic potential of Vigna unguiculata
  • 21 Aug 2025
  • Drug Target Insights

FAQs on Drug Target Insights